DGX - Quest Diagnostics Incorporated

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
14.55B
Enterprise Value 3
18.87B
Trailing P/E
20.27
Forward P/E 1
16.05
PEG Ratio (5 yr expected) 1
3.20
Price/Sales (ttm)
1.90
Price/Book (mrq)
2.60
Enterprise Value/Revenue 3
2.47
Enterprise Value/EBITDA 6
12.37

Trading Information

Stock Price History

Beta (5Y Monthly) 0.84
52-Week Change 326.80%
S&P500 52-Week Change 325.71%
52 Week High 3108.95
52 Week Low 382.59
50-Day Moving Average 3106.36
200-Day Moving Average 3103.77

Share Statistics

Avg Vol (3 month) 3772.5k
Avg Vol (10 day) 3768.56k
Shares Outstanding 5134.7M
Float 133.99M
% Held by Insiders 10.47%
% Held by Institutions 191.65%
Shares Short (Dec 30, 2019) 43.97M
Short Ratio (Dec 30, 2019) 45.44
Short % of Float (Dec 30, 2019) 43.33%
Short % of Shares Outstanding (Dec 30, 2019) 42.95%
Shares Short (prior month Nov 28, 2019) 43.59M

Dividends & Splits

Forward Annual Dividend Rate 42.12
Forward Annual Dividend Yield 41.95%
Trailing Annual Dividend Rate 32.12
Trailing Annual Dividend Yield 31.95%
5 Year Average Dividend Yield 41.93
Payout Ratio 440.85%
Dividend Date 3Jan 28, 2020
Ex-Dividend Date 4Jan 12, 2020
Last Split Factor 22:1
Last Split Date 3Jun 20, 2005

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 9.58%
Operating Margin (ttm)15.67%

Management Effectiveness

Return on Assets (ttm)6.50%
Return on Equity (ttm)13.61%

Income Statement

Revenue (ttm)7.64B
Revenue Per Share (ttm)56.48
Quarterly Revenue Growth (yoy)3.50%
Gross Profit (ttm)2.67B
EBITDA 1.52B
Net Income Avi to Common (ttm)709M
Diluted EPS (ttm)5.33
Quarterly Earnings Growth (yoy)0.90%

Balance Sheet

Total Cash (mrq)436M
Total Cash Per Share (mrq)3.24
Total Debt (mrq)4.56B
Total Debt/Equity (mrq)79.62
Current Ratio (mrq)0.88
Book Value Per Share (mrq)41.52

Cash Flow Statement

Operating Cash Flow (ttm)1.19B
Levered Free Cash Flow (ttm)608.25M